Now that CMS has expanded CPAP coverage for OSA patients diagnosed via home sleep testing devices types II, III, and IV, will HST encourage patients to flock to your door?
CMS has expanded its coverage for CPAPs to include beneficiaries diagnosed with obstructive sleep apnea via home sleep testing devices types II, III and IV.
The Centers for Medicare & Medicaid Services (CMS) announced Dec. 14 that it is proposing to change its national coverage determination (NCD) to include payment for CPAP equipment when the sleep apnea diagnosis is based on results from home sleep testing (HST).
HME Business partners with Wachovia throughout the year to provide our readers with the latest data on the sleep market. This latest survey of HME providers, conducted during Q4 2007 shows the sleep market is still going strong, and CPAP pricing is currently stable, but reimbursement rates for HME suppliers could be hurt by the upcoming national competitive bidding (NCB) program. Findings also included expected growth in the negative pressure wound therapy (NPWT) market. Read the PDF to learn more!
The sleep market is still going strong, and CPAP pricing is currently stable, but reimbursement rates for HME suppliers could be hurt by the upcoming national competitive bidding (NCB) program, say the results of the latest Wachovia HME Sleep & Wound Care Survey. Findings also included expected growth in the negative pressure wound therapy (NPWT) market.